Switch to:

NovoCure DeferredTaxAndRevenue

: $0.0 Mil (As of Mar. 2019)
View and export this data going back to 2015. Start your Free Trial

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

NovoCure's current deferred tax and revenue for the quarter that ended in Mar. 2019 was $0.0 Mil.

NovoCure DeferredTaxAndRevenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

NovoCure Annual Data

Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
DeferredTaxAndRevenue Premium Member Only 0.00 0.05 2.27 4.96 8.84

NovoCure Quarterly Data

Dec13 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
DeferredTaxAndRevenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 8.84 0.00

NovoCure DeferredTaxAndRevenue Explanation


NovoCure DeferredTaxAndRevenue Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK